D-dimer as a marker of acute pyelonephritis in infants younger than 24 months with urinary tract infection
暂无分享,去创建一个
[1] S. Rašić,et al. Inflammatory Markers and Procoagulants in Chronic Renal Disease Stages 1-4 , 2015, Medical archives.
[2] A. Winkler,et al. The influence of various patient characteristics on D-dimer concentration in critically ill patients and its role as a prognostic indicator in the intensive care unit setting. , 2014, Clinics in Laboratory Medicine.
[3] K. Yoo,et al. Predictive value of urinary and serum biomarkers in young children with febrile urinary tract infections , 2014, Pediatric Nephrology.
[4] C. Combescure,et al. Effects of impaired renal function on levels and performance of D-dimer in patients with suspected pulmonary embolism , 2014, Thrombosis and Haemostasis.
[5] K. Lue,et al. Comparison of procalcitonin and different guidelines for first febrile urinary tract infection in children by imaging , 2014, Pediatric Nephrology.
[6] A. Gervaix,et al. Association of Procalcitonin With Acute Pyelonephritis and Renal Scars in Pediatric UTI , 2013, Pediatrics.
[7] F. Jaimes,et al. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. , 2012, The American journal of emergency medicine.
[8] A. Tripodi. D-Dimer Testing in Laboratory Practice* , 2012 .
[9] W. Raszka,et al. Preparing Future Pediatricians: Making Time Count , 2011, Pediatrics.
[10] A. Gervaix,et al. Procalcitonin is a predictor for high-grade vesicoureteral reflux in children: meta-analysis of individual patient data. , 2011, The Journal of pediatrics.
[11] K. Roberts. Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months , 2011, Pediatrics.
[12] Ji-Eun Kim,et al. Neutrophil and monocyte activation markers have prognostic impact in disseminated intravascular coagulation: in vitro effect of thrombin on monocyte CD163 shedding. , 2011, Thrombosis research.
[13] M. Huisman,et al. The use of D-dimer in specific clinical conditions: a narrative review. , 2009, European journal of internal medicine.
[14] Markus Lins,et al. Thrombophiler Status bei Patienten mit entzündlichen Erkrankungen , 2008 .
[15] S. Kitchen,et al. Laboratory D-dimer measurement: Improved agreement between methods through calibration , 2007, Thrombosis and Haemostasis.
[16] L. Young,et al. Diagnostic significance of clinical and laboratory findings to localize site of urinary infection , 2007, Pediatric Nephrology.
[17] E. Yılmaz,et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis , 2005, Pediatric Nephrology.
[18] D. Stirling,et al. Interleukin 6 and Haemostasis , 2001, British journal of haematology.
[19] A. Biggi,et al. Acute renal cortical scintigraphy in children with a first urinary tract infection , 2001, Pediatric Nephrology.
[20] P. Libby,et al. Inflammation and thrombosis: the clot thickens. , 2001, Circulation.
[21] E. Kass,et al. Paediatric urinary tract infection and the necessity of complete urological imaging , 2000, BJU international.
[22] S. Mårild,et al. Incidence rate of first‐time symptomatic urinary tract infection in children under 6 years of age , 1998, Acta paediatrica.
[23] C. Schulman,et al. Can careful ultrasound examination of the urinary tract exclude vesicoureteric reflux in the neonate? , 1997, The British journal of radiology.
[24] J. Miller,et al. Procedure guideline for renal cortical scintigraphy in children. Society of Nuclear Medicine. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] M. Lavocat,et al. Imaging of pyelonephritis , 1997, Pediatric Radiology.
[26] S. Robson,et al. Fibrin degradation product D‐dimer induces the synthesis and release of biologically active IL‐1β, IL‐6 and plasminogen activator inhibitors from monocytes in vitro , 1994, British journal of haematology.
[27] H. G. Rushton,et al. Dimercaptosuccinic acid renal scintigraphy for the evaluation of pyelonephritis and scarring: a review of experimental and clinical studies. , 1992, The Journal of urology.
[28] J. Gauldie,et al. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. , 1990, Journal of immunology.
[29] D. Fitzmaurice,et al. Appropriate use of D-dimer in hospital patients. , 2010, The American journal of medicine.
[30] R. L. Lebowitz,et al. International system of radiographic grading of vesicoureteric reflux , 2006, Pediatric Radiology.
[31] L. Lins,et al. Long-term prognosis of post-infectious renal scarring in relation to radiological findings in childhood — a 27-year follow-up , 2004, Pediatric Nephrology.
[32] M. Lins,et al. [The thrombophilic status of patients with inflammatory diseases]. , 1996, Deutsche medizinische Wochenschrift.